AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 21st, 2023 • MedTech Acquisition Corp • Services-medical laboratories • Colorado
THIS AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of March 2, 2023 (the “Effective Date”), between TriSalus Life Sciences, Inc., a Delaware corporation (the “Company”), and Sean Murphy (“Executive”).
STRATEGIC COLLABORATION AGREEMENTStrategic Collaboration Agreement • April 21st, 2023 • MedTech Acquisition Corp • Services-medical laboratories • Texas
This Strategic Collaboration Agreement (“Agreement”), effective as of the 2nd day of March, 2021 (“Effective Date”), is entered into by and between The University of Texas M. D. Anderson Cancer Center, with a place of business located at 1515 Holcombe Blvd., Houston, TX 77030, USA (“MD Anderson”), a member institution of The University of Texas System (“System”) and Surefire Medical Inc., dba TriSalus™ Life Sciences with a place of business located at 6272 W. 91st Avenue, Westminster, CO (“Company”) (MD Anderson and each a “Party” and collectively the “Parties”).
ASSET PURCHASE AGREEMENT by and between Dynavax Technologies Corporation (“Dynavax”) and Surefire Medical Inc. d/b/a TriSalus Life Sciences (“TriSalus”) DATED AS OF JULY 31, 2020Asset Purchase Agreement • April 21st, 2023 • MedTech Acquisition Corp • Services-medical laboratories • Delaware
THIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of July 31, 2020, by and between Dynavax Technologies Corporation, a Delaware corporation (“Dynavax”), and Surefire Medical, Inc., a Delaware corporation d/b/a TriSalus Life Sciences (“TriSalus,” and with Dynavax, each a “Party” and, together, the “Parties”).
